Translate
Astrazeneca Plc
About
Astrazeneca Plc (LSE:AZN) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older
Yesterday
Breztri approved in the US for asthma
Apr 27 2026
Saphnelo self-administration approved in the US
Apr 21 2026
I CAN PhIII interim analysis met primary endpoint
Apr 20 2026
Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
Financials
Revenue
GBX58.74 B
Market Cap
GBX237.53 B
P/E Ratio
31.13
EPS
4.92
Dividend Yield
2.13%